GOLDMAN SACHS GROUP INC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 90 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$905,113
+9.7%
239,448
+94.4%
0.00%
Q2 2023$825,125
-35.5%
123,153
-37.3%
0.00%
Q1 2023$1,279,241
+32.8%
196,504
+74.1%
0.00%
Q4 2022$962,994
+83.1%
112,895
+13.3%
0.00%
Q3 2022$526,000
+0.6%
99,652
-19.2%
0.00%
Q2 2022$523,000
+46.5%
123,286
+21.2%
0.00%
Q1 2022$357,000
-31.5%
101,691
+30.0%
0.00%
Q4 2021$521,000
-4.1%
78,233
+43.9%
0.00%
Q3 2021$543,000
-86.7%
54,349
-38.1%
0.00%
-100.0%
Q4 2020$4,069,00087,8130.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$26,123,9999.73%
Nextech Invest Ltd. 1,910,029$12,434,2895.19%
K2 PRINCIPAL FUND, L.P. 2,686,490$17,489,0512.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$72,117,3051.61%
Orbimed Advisors 8,740,887$56,903,1741.12%
SECTORAL ASSET MANAGEMENT INC 793,587$5,166,2510.99%
Tejara Capital Ltd 207,555$1,351,1830.69%
Rubric Capital Management LP 3,480,712$22,659,4350.59%
Resolute Capital Asset Partners LLC 120,000$7810.57%
RA Capital Management 3,009,678$19,593,0040.44%
View complete list of SILVERBACK THERAPEUTICS INC shareholders